NIFTY 50

Zydus Cadila looks to complete phase-II trials of COVID-19 vaccine candidate in 1-2 months

Updated : August 12, 2020 07:49 PM IST

Drug firm Zydus Cadila on Wednesday said it's hopeful of completing phase-II of clinical trials of its COVID-19 vaccine candidate ZyCoV-D in 1-2 months.

In an interview to CNBC-TV18's Shereen Bhan, Sharvil Patel, the managing director, said, "Our technology is useful in development of COVID-19 vaccine and is scalable."

Patel said the company would be building 100 million doses of capacity for the vaccine and will start manufacturing COVID vaccine if phase II data is good."
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you